Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-28

Clinical Trial Update: Effect of Remote Ischemic Preconditioning on the Incidence of Contrast Induced Nephropathy in Patients Undergoing EVAR [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether remote ischemic preconditioning reduces contrast-induced nephropathy in patients undergoing endovascular aortic repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery | Conditions: Aortic Aneurysm, Ischemic Preconditioning | Phase 2 | Status: COMPLETED